International News

Düsseldorf (Germany) – The next edition of Interpack, scheduled to take place from 7 to 13 May in Düsseldorf, will devote significant space to the paradigms of the circular economy. The packaging industry is increasingly focusing on solutions designed to reduce environmental impact throughout the entire product lifecycle.

Jena/Göttingen, March 18, 2026 – Analytik Jena, together with its subsidiary Biometra, is celebrating four decades of technological excellence in molecular biology. Since its founding in 1985, Biometra has had a significant impact on laboratory practice – from early electrophoresis systems to pioneering PCR thermocyclers and modern platforms enabling automated, highly precise workflows. This success story is defined by customer proximity, engineering expertise, and a steadfast commitment to quality.

Jena / Germany, October 14, 2025 – Analytik Jena has expanded its qPCRsoft 6.0 software for the qTOWER iris with an optional module for 21 CFR Part 11 compliance. This enhancement ensures the software now meets the requirements of the U.S. FDA regulation for electronic records and signatures—a crucial step for laboratories operating in regulated environments such as pharmaceuticals, biotechnology, and GxP settings.

Hyderabad, India – September 22, 2025 – Corning Incorporated (NYSE: GLW) and SGD Pharma today announced the inauguration of a new glass tubing facility in Telangana, which will expand pharmaceutical manufacturing in the region. The new facility will bring together Corning’s state-of-the-art Velocity® Vial technology and SGD Pharma’s vial-converting expertise, helping address capacity challenges and quality requirements in primary glass packaging.

The new plant will manufacture highquality Type I borosilicate glass tubing, a critical material used for injectable drug packaging, direct injection delivery systems, diagnostics, and biologics. By combining SGD
Pharma’s vial-converting expertise with Corning’s proprietary Velocity Vial glass-coating technology, the collaboration will enhance vial quality, improve filling-line productivity, and accelerate the delivery of injectable treatments. With tubing production and vial converting co-located, the facility will also deliver efficiencies in sustainability and product quality.

“The inauguration of this facility marks an important milestone in addressing critical regional needs, such as expanded production capacity, proximity to customers, and the localization of supply chains,” said Chris Hudson, Vice President and General Manager, Corning Life Sciences. “This facility will play a vital role in India in accelerating the delivery of injectable treatments, supporting local pharmaceutical growth, and ensuring safer, more efficient access to critical medicines.”

“This joint venture with Corning marks a major milestone in our global growth strategy. By establishing a state-of-the-art glass tubing facility in Telangana, we are not only securing a critical part of our supply chain but also bringing world-class technology to one of the fastestgrowing pharmaceutical markets,” said Olivier Rousseau, CEO, SGD Pharma. “This investment reinforces our commitment to innovation, sustainability, and supporting local development, while positioning SGD Pharma as a truly global leader in high-quality glass packaging.”

The new facility will also allow Corning to better serve customers in the region, ensuring faster lead times and strengthening supply chain resilience. This localized manufacturing capacity will also help broaden the adoption of advanced glass tubing solutions for safer and more efficient delivery of critical medicines.

“This project reflects a strong commitment to the region and to our long-term vision,” said Sudhir Pillai, Managing Director, Corning India. “It creates hundreds of local jobs, boosts the regional economy, and supports India’s aspirations of self-reliance and sustainable growth. At the same time, it reinforces Corning’s global leadership in pharmaceutical glass packaging, underscores its vital role in driving progress across the industry, and aligns with our strategy to localize manufacturing and expand our global presence.”

“We are proud to inaugurate this state-of-the-art glass tubing facility in Telangana, a testament to SGD Pharma’s commitment to advancing pharmaceutical manufacturing in India,” said Deepak Sood, General Manager, SGD Pharma India. “This facility not only strengthens our local manufacturing capabilities but also enables us to bring Corning’s Velocity Vial technology to the region—enhancing product quality, improving operational efficiency, and supporting the evolving needs of our pharmaceutical partners.”
SGD Pharma joins a growing network of primary-packaging leaders adopting Corning’s cuttingedge coating technology. The new site expands Velocity Vial the manufacturing footprint for Corning’s Velocity Vials and enables easier adoption of the technology by customers across markets.

The joint venture between Corning and SGD Pharma was incorporated in April 2023, followed by a facility groundbreaking in June 2023. Phase one for Velocity Vials production started in March 2024, followed by tubing production in late 2025.

Milan (Italy) – Marchesini Group, a leader in packaging machinery for the pharmaceutical and cosmetics industry, will be exhibiting at the upcoming edition of Pharmintech powered by Ipack-Ima, the exhibition dedicated to innovations and solutions in processing and packaging, being held in Milan, Italy from May 27 to 30, 2025.

The trade fair will be an opportunity for Marchesini Group to engage in discussions and networking, looking towards 2025 with cautious optimism after the good results of 2024, which saw consolidated turnover of over 600 million Euros. “We are satisfied with the results achieved last year; the Group has continued to grow steadily,” commented Valerio Soli, CEO of Marchesini Group. “We aim to reach a billion Euros of revenue in the medium-short term through further acquisitions and business opportunities in new geographical areas. With the goal of offering increasingly complete and integrated lines to our customers, we have decided to showcase in Milan some machine models which are capable of packaging various types of drugs and cosmetics, without neglecting our digital services featuring artificial intelligence.”

Solutions on show at stand A26 B25 – Hall 2

At Pharmintech powered by Ipack-Ima, the Group will be exhibiting a wide range of solutions for the pharmaceutical and cosmetics industry: from processing machines to primary packaging of solid, liquid, and powder products, with a corner dedicated to digital technologies.

With regard to the pharmaceutical business, there will be two main focuses: on the one hand, solutions for powder filling, which the Group has been emphasizing recently thanks to the integration of the MAR brand; on the other hand, process technologies with the Dumek brand, increasingly oriented towards pharmaceutical production and compliance with sector regulations.

On display at the stand will be a powder filling machine with vacuum-pressure disk filling technology and 100% IPC, and a vacuum turboemulsifier for processing liquid or cream products, featuring an interactive system that shows off the various production phases.

There will also be a monoblock for blister packaging integrated with the new alternating cartoner, capable of handling a wide range of formats at a maximum speed of 150 pieces per minute. Rounding off the offering will be a selection of Dott. Bonapace branded laboratory machines, including a complete line for filling, cooling, and sealing ovules and suppositories; a two-channel system for counting and filling bottles with tablets, capsules, and pills; as well as a capsule filler and a rotary tablet press.

As regards the cosmetics sector, on the other hand, the Beauty Division will be showcasing a line for tubes, first filled and closed by an Axomatic tube filler, then placed in cartons by the V2 engineering horizontal alternating motion cartoner. Also on display will be a line developed through the collaboration between the Vibrotech and Axomatic brands, consisting of a robotic feeding system perfectly integrated with a linear filling and capping machine for stable bottles.

The technologies of the Digital division (including predictive maintenance, the Customer Portal, and augmented reality format change) will also be featured, along with vision systems from SEA Vision, celebrating its 30 years of experience in the sector at the stand.

Waiblingen (Germany), April 2, 2025 – Syntegon, a strategic partner of the pharmaceutical and food industries, is continuing its successful development and preparing for the next phase of its growth strategy. With the sale of its former site in Waiblingen to Andreas Stihl AG & Co. KG, and the planned relocation of its production and administration activities to Fellbach and Bad Cannstatt (Stuttgart) this year, Syntegon is setting the ideal conditions for further growth.

Hundred-gram scale synthesis enables discovery and early development for conjugated drug development

Luar es un un laboratorio farmacéutico que ofrece servicios de elaboración para terceros. Cuenta con una amplia gama de servicios de producción y una planta farmacéutica habilitada para:

With cases of avian influenza A (H5N1) continuing to rise among cattle and humans in the US, scientists and government health officials are preparing for the potential of the virus adapting to enable human-to-human transmission. While there is no evidence yet that H5N1 could spread between humans, pandemic preparedness is essential, and mRNA vaccines offer great potential to mitigate a future pandemic, says GlobalData, a leading data and analytics company.

The inaugural Pharma Logistics Winter University, co-founded by the Department of Health – Abu Dhabi, Etihad Cargo, Pharma.Aero, the University of Antwerp, and Khalifa University of Science and Technology, offers an immersive five-day programme in Abu Dhabi, bridging academic learning with practical application to cultivate future global leaders in pharmaceutical logistics.